Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.
Canaani J, Labopin M, Socié G, Nihtinen A, Huynh A, Cornelissen J, Deconinck E, Gedde-Dahl T, Forcade E, Chevallier P, Bourhis JH, Blaise D, Mohty M, Nagler A. Canaani J, et al. Among authors: nihtinen a. Am J Hematol. 2017 Jul;92(7):653-659. doi: 10.1002/ajh.24737. Epub 2017 May 26. Am J Hematol. 2017. PMID: 28370339 Free article.
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.
Ruutu T, Juvonen E, Remberger M, Remes K, Volin L, Mattsson J, Nihtinen A, Hägglund H, Ringdén O; Nordic Group for Blood and Marrow Transplantation. Ruutu T, et al. Among authors: nihtinen a. Biol Blood Marrow Transplant. 2014 Jan;20(1):135-8. doi: 10.1016/j.bbmt.2013.10.014. Epub 2013 Oct 17. Biol Blood Marrow Transplant. 2014. PMID: 24141008 Free article. Clinical Trial.
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation.
Cesaro S, Tridello G, Blijlevens N, Ljungman P, Craddock C, Michallet M, Martin A, Snowden JA, Mohty M, Maertens J, Passweg J, Petersen E, Nihtinen A, Isaksson C, Milpied N, Rohlich PS, Deconinck E, Crawley C, Ledoux MP, Hoek J, Nagler A, Styczynski J. Cesaro S, et al. Among authors: nihtinen a. Clin Infect Dis. 2018 Aug 1;67(4):564-572. doi: 10.1093/cid/ciy150. Clin Infect Dis. 2018. PMID: 29481599
Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single centre cohort with a long follow-up.
Martelin E, Volin L, Itälä-Remes M, Niittyvuopio R, Lindström V, Heiskanen J, Ruutu T, Nihtinen A. Martelin E, et al. Among authors: nihtinen a. Bone Marrow Transplant. 2019 Feb;54(2):334-337. doi: 10.1038/s41409-018-0290-6. Epub 2018 Aug 13. Bone Marrow Transplant. 2019. PMID: 30104720 No abstract available.
Long-term outcome after allogeneic stem cell transplantation in multiple myeloma.
Luoma S, Silvennoinen R, Rauhala A, Niittyvuopio R, Martelin E, Lindström V, Heiskanen J, Volin L, Ruutu T, Nihtinen A. Luoma S, et al. Among authors: nihtinen a. Ann Hematol. 2021 Jun;100(6):1553-1567. doi: 10.1007/s00277-021-04514-y. Epub 2021 Apr 17. Ann Hematol. 2021. PMID: 33866396 Free PMC article.
33 results